Pancreatic CancerView this Special Issue
Clinical Study | Open Access
Hind Right Approach Pancreaticoduodenectomy: From Skill to Indications
Background. Pancreaticoduodenectomy is the potentially curative treatment for malignant and several benign conditions of the pancreatic head and periampullary region. While performing pancreaticoduodenectomy, early neck division may be impossible or inadequate in case of hepatic artery anatomic variants, suspected involvement of the superior mesenteric vessels, intraductal papillary mucinous neoplasm, and pancreatic head bleeding pseudoaneurysm. Our work aims to highlight a particular hind right approach pancreaticoduodenectomy in selected indications and assess the preliminary results. Methods. We describe our early hind right approach to the retropancreatic vasculature during pancreaticoduodenectomy by mesopancreas dissection before any pancreatic or digestive transection. Results. We used this approach in 52 patients. Thirty-two had hepatic artery anatomic variant and 2 had bleeding pancreatic head pseudoaneurysm. The hepatic artery variant was preserved in all cases out of 2 in which arterial reconstruction was performed. In nine patients with intraductal papillary mucinous neoplasms the pancreaticoduodenectomy was extended to the body in 6 and totalized in 3 patients. Seven patients with adenocarcinoma involving the portomesenteric axis required venous resection and reconstruction. Conclusions. Early hind right approach is advocated in selected cases of pancreaticoduodenectomy to improve locoregional vascular control and determine, safely and early, whether there is mesopancreas involvement.
Pancreaticoduodenectomy (PD) is the treatment of choice for malignant and several benign conditions of the pancreatic head and periampullary region [1–4]. Since the first PD performed by Whipple in 1937, more than 70 technical improvements have been made, mainly related to pylorus preservation or reconstruction of pancreatico-digestive continuity and much less regarding the type of resection [1, 5–7]. Standard PD is usually performed with transection of the pancreatic neck before the superior mesenteric artery (SMA) dissection [8–10]. However, since the limited involvement of portomesenteric vein is no longer considered unresectable disease, the resectability is now assessed by whether or not the SMA is involved . Moreover, the extended indications of PD in case of tumors associating hepatic artery (HA) variants or invading the mesentericoportal axis (borderline resectable pancreatic head adenocarcinomas) , as well as the importance to achieve R0 posteromedial resection margins (in adenocarcinomas and main duct-intraductal papillary mucinous neoplasms-MD-IPMN) , led to the development of so called “artery first” approaches . Notable amongst these is an early right posterior approach to the superior mesenteric vessels, with mesopancreas (MP) dissection close to the origin of the SMA. The aim is to assess the resectability before taking an irreversible step, and variants of the arterial blood supply to the liver, to undertake the mobilization of the specimen before pancreatic or digestive division, and, if necessary, the safe venous clamping [5, 13–26].
We have adopted this hind right approach to the SMA since 2007 and have been using it combined with the early isolation and dissection free of the superior mesenteric vein (SMV) beneath the pancreas, as our “standard approach” PD in selected indications such as HA anatomic variants, suspected involvement of mesentericoportal axis or SMA, MD-IPMN, and pancreatic head bleeding pseudoaneurysm. It is very suitable to early assess the infiltration of SMV and SMA, allowing appropriate handling at the initial stages of the resection itself.
Although we have previously reported this approach related to PD in case of HA variants [5, 6], whereas we extended the indications, we describe how, when, and why to perform this modified right retropancreatic vascular approach PD and our current experience.
One hundred fifty consecutive patients have been registered for PD for benign and malignant diseases of the periampullary and pancreatic head region between January 1, 2007 and February 28, 2014. Among them, 52 (30 males and 22 females, median age 56.7 years; range 40–78 years) underwent PD with early hind right dissection. Patient characteristics are presented in Table 1. In 32 patients, the preoperative multidetector computed tomography revealed HA anatomic variants (Table 1): aberrant right HA (RHA) and replaced common HA (RCHA), with retropancreatic (28 cases) or intrapancreatic (4 cases) and retroportal course. Seven patients with adenocarcinoma had the added involvement of the portomesenteric vein. Nine patients with MD-IPMT were preoperatively assessed by abdominal multidetector computed tomography and endoscopic ultrasound with guided fine needle aspiration biopsy. A bleeding pancreatic head pseudoaneurysm was disclosed by computed tomography in 2 patients.
The procedures were performed by the same trained surgical team.
3. Surgical Technique
The pancreas head is exposed by an extended Kocher maneuver carried out beyond the aorta, incision of the attachment of the transverse mesocolon to the right Gerota fascia, and opening of the lesser sac by separating greater omentum and transverse colon using a Liga-Sure device. The superior mesenteric vein (SMV) is early isolated below the pancreas, where it passes over the third duodenum and is dissected free from the pancreas and uncinate process (Figures 1 and 2), with ligation of the right gastroepiploic and inferior pancreaticoduodenal veins and early creation of a tunnel between pancreas and portomesenteric axis towards the hepatic pedicle (Figures 2 and 3). This step early detects whether or not the portomesenteric vein is involved and assesses the infiltration status of the infrapancreatic SMA. Behind the pancreas, the dissection must surpass the aorta to get full posterior leftwards mobilization of the duodenopancreas, and the plane between the SMV and the SMA is identified as part of the MP (Figures 2 and 3).
The retropancreatic dissection is carried on downwards from the inferior border of the Winslow foramen along the Treitz fascia, exposing the inferior vena cava on its left side, the upper margin of the left renal vein, and, in between, the origin of the SMA along with the posterior pancreatic capsule (Figures 2, 3, and 4).
The SMA origin is identified in this angle, and along its adventitial plane the MP (including RPL or retropancreatic medial margin) is dissected and removed “step-by-step.” The MP is inserted on its right aspect, in a frontal plane behind the pancreas (Figures 2, 3, and 4). This dissection is pursued over 3-4 cm, from the SMA origin until its entrance into the mesentery, using progressive exposure and gentle medial retraction of the portal vein (PV), which is also freed from the MP (Figures 3 and 4). The superior and inferior pancreaticoduodenal arteries are identified and ligated (Figure 4). The MP is retracted to the right and all lymphatic and perineural tissue between SMA and SMV is removed to achieve negative resection margins. Possible SMA invasion can be early detected, due to MP involvement, avoiding the risk of nonradical resection. Complete excision of the connective tissue between the origin of the SMA and the (CT) is performed as well. This exposure enables the dissection of a RHA originating from SMA or CT (Figure 3) or a RCHA arising from the SMA (Figures 4 and 5). The vessel usually arising 1-2 cm from the SMA origin is looped and freed from the MP, upwards to the hepatic pedicle (Figures 3, 4, and 5). Its safeguarding is generally possible. To facilitate the SMA and aberrant RHA or RCHA dissection, the duodenopancreas is retracted en bloc upwards, ventrally and to the left. Limited dissection along the right side of the SMA is advocated (Figures 2, 3, and 4), to avoid extensive removal of the perivascular nervous plexus, resulting in postoperative intestinal motility troubles.
The hepatic pedicle is approached after this extended dissection. The cholecystectomy is performed, the common and proper HAs are isolated, and the right gastric vessels and gastroduodenal artery are identified and clamped to make sure that the arterial flow either in hepatic or gastric arteries remains normal and there is no unrecognized CT stenosis. The gastroduodenal artery is divided, as well as the common bile duct above the entry of the cystic duct (Figures 3 and 4). This improves the exposure of the suprapancreatic PV. During periportal lymphadenectomy one should be aware of an eventual accessory or replaced RHA originating from the SMA or CT, or to a RCHA from the SMA. If present, this vessel running upwards behind the PV is looped (Figures 3 and 4). The SMV is entirely dissected at the inferior pancreatic margin with ligation of all veins draining the uncinate process, which is exposed up to the right side of the SMA. At this stage the posterior wall of the portomesenteric axis is entirely exposed. The Treitz ligament is divided, allowing mobilization of the duodenojejunal junction, so the specimen to be removed reaches the right side of the mesenteric root.
Once the radicality of PDR is established jejunal and distal gastric division are undertaken according to Whipple procedure using stapling devices. The last step of the resection is the pancreatic neck transection, just in front of the PV using a usual “cold” scalpel. When pancreatic division must be deviated towards the body, the dorsal pancreatic artery and collaterals of both the SMA and the SMV (from the lower edge of the pancreas) are divided. In case of involvement of the portomesenteric confluence, the splenic vein is controlled behind the body. Adequate mobilization of the mesentery and right colon is necessary to perform safely “en bloc” resection and venous reconstruction. This mobilization is useful in case of limited portomesenteric invasion, in order to avoid vein grafting during venous reconstruction.
In case of IPMN extending from the head to the body, the retropancreatic mobilization is done leftwards and the splenic vessels are dissected with successive ligation of their collaterals. When the pancreatic body is mobilized sufficiently the pancreas can be divided at any level, or entirely removed. Frozen section analysis is performed at the sectioned champs, to assess the malignant status of the remnant pancreas. Reconstruction phase, drainage, and postoperative care are similar to those from standard PD. During the operative procedure we use standard dissection and ligatures, monopolar section and coagulation. The Liga-Sure device is used during Kocher maneuver and division of the lesser and greater omentum.
HA variants were intraoperatively confirmed in all 32 cases. The aberrant vessel was preserved in 30 cases. A RCHA originating from the SMA was involved by an enlarged lymph nodes mass behind the pancreatic head (borderline resectable pancreatic head cancer) in 2 patients, so a segmental resection of the involved RCHA had to be performed with arterial reconstruction, using the reversed splenic artery in both cases. Right hind approach PD was also performed in emergency in two cases of pancreatic head bleeding pseudoaneurysm, with early ligation of the pseudoaneurysm feeding artery, originating from the inferior pancreaticoduodenal artery. Seven patients with borderline resectable ductal adenocarcinoma involving the portomesenteric confluence required en bloc resection, mobilization of the right colon, and mesentery root followed by mesentericoportal veno-venous suture. When vascular reconstruction was required, clamping time did not exceed 22 minutes. Anastomotic patency and normal blood flow were confirmed by Doppler ultrasound at the end of the procedure.
The same approach was used in 9 patients with MD-IPMN (6 PD extended to the body-IPMN in the head, uncinate, or neck and 3 total PD-IPMN diffusely involving the main pancreatic duct).
Since we routinely perform this approach in selected indications, no conversion to standard PD was undertaken.
The median operative time was 295 minutes (range 225–435) and median blood loss was 760 mL (range 215–1090). The short-term outcome related to this approach is shown in Table 2. For the malignant tumors, a R0 resection was achieved in 32 patients and a R1 resection in 5 patients (14%), (all with borderline resectable pancreatic head cancers). No R2 resection was noted. The follow-up has lasted until patient death or until the cut-off date of February 28, 2014. The median follow-up time was 32.5 months (range 6.5–72). At the time of the last follow-up, 39 patients were still alive. If only patients with pancreatic cancer were taken into account, median survival time was 19.1 months (range 8.5–32).
Because of continuous decrease in mortality rate, PD is nowadays routinely performed for tumors of the pancreatic head and periampullary region, with or without invasion of the mesentericoportal axis and even in IPMN. The early hind approach to the MP during PD on the right side of the SMA, before the digestive and pancreatic continuity that should be interrupted, is of particular interest in case of HA abnormality, with RHA originating from SMA or CT, or RCHA from the SMA, suspected involvement of the SMA, MD-IPMN extended from the pancreatic head to the body, and involvement of the portomesenteric axis. Recently we performed in emergency this hind right approach Whipple in two patients with bleeding pancreatic head pseudoaneurysm. In this setting, early ligation of the inferior pancreaticoduodenal artery (feeding the bleeding pancreatic head pseudoaneurysm) enabled a steady hemostasis and removal of the lesion. From the technical variants described as “artery first” approach to PD , we routinely adopted a right posterior approach to the SMA, additionally combined with early isolation and dissection free of the SMV beneath the pancreas (Figures 1, 2, and 3). It has become the standard practice in our unit in the above mentioned indications. The potential advantage of this approach is that technical difficulties, which may be encountered either due to tumor infiltration of the SMA, SMV, or the main PV, can be clearly assessed and handled appropriately at the initial stages of the resection itself. It gathers the advantages of a posterior “artery first” approach PD with a modified uncinate process first approach, regarding the following:(1)identification of SMA involvement either at the origin or at uncinate;(2)identification of the portomesenteric vein involvement requiring en bloc resection;(3)identification and preservation of HA variants;(4)adequate retropancreatic lymphadenectomy;(5)minimal bleeding by early ligation of the IPDA and IPDV;(6)effectiveness in obesity, postchemotherapy status, and peripancreatic inflammation;(7)mobilization of the whole gland before transection;(8)removal of large tumors of the pancreatic head extending to the uncinate.
Standard PD implies the creation of a tunnel between the pancreatic neck and the PV, followed by neck transection so the pancreatic continuity is interrupted before radicality of the resection can be assessed. The late determination of the MP infiltration status means that the surgeon is already committed to resection. Even in some recent series, nonradical PD is presented [27, 28]. Moreover, in the standard PD, dissection of a RHA or RCHA is usually performed late, when bleeding from the resection specimen decreases the exposure of the SMA and of an aberrant RHA. Early neck transection is also not suitable when the pancreatic neck and/or the portomesenteric axis are involved [18, 19] or in MD-IPMN extended to the body or diffusely affecting the pancreas [12, 16, 17]. One of the difficulties of PD lies in the variability of peripancreatic vascular anatomy. Preoperative assessment of variant pattern of the arterial blood supply to the liver (variants, strictures) is necessary to avoid unnecessary complications, such as fatal hepatic injury [29, 30]. Accidental ligation of HA may result in hepatic necrosis, ischemic biliary tract injury, or anastomotic complications [31, 32]. Moreover, injury of an aberrant HA during PD relates to a breakdown of bilioenteric anastomosis, because the blood supply to the cranial part of the common bile duct is entirely dependent on the RHA after PD [32–34]. RHA or RCHA from SMA may be situated behind or within the pancreas head or along its ventral side [35–37]. We could not confirm its course before dissecting and isolating it from the SMA origin within the MP dissection. In our series, in the vast majority of patients with HA anatomic variant, the aberrant vessel was spared. In two patients this artery was willingly sacrificed for oncological reasons, but reconstructed.
Pancreatic head carcinoma with venous limited involvement can be safely resected with a long-term survival similar to that observed after radical resection without venous involvement [13, 18, 23, 38, 39]. In such situation, the best option is to perform “en bloc” venous resection in order to obtain R0 resection . By using the hind right approach, after transection of the pancreatic isthmus, the tumor remains attached only to the involved veins, so clamping of the portomesenteric confluence is easier and shorter [39, 40]. Mobilization of the right colon and mesentery root are useful to avoid vein grafting during reconstruction of the PV . Since the pancreatic transection is performed at the end, congestion and bleeding are less likely whereas the venous drainage of both the specimen and bowel are compromised minimally during most of the procedure [20, 25]. Moreover, there is a reduced intraoperative blood loss, due to an early ligation of the inferior pancreaticoduodenal artery [20, 40].
In MD-IPMN, the most frequent localization is the pancreatic head, but involvement of the body may occur [12, 16, 17]. In this setting and particularly in malignancies , en bloc resection requires pancreatic division of the body rather than the neck. Early hind right approach to the MP facilitates pancreatic mobilization towards the left. By the early approach to the SMV beneath the pancreas, our technique enables the total pancreatectomy as mobilization can be achieved without transecting gland. In fact, final transection of the pancreas can be performed at the desired place if it is enough separated from the splenic vessels, preventing tumor opening, which might disseminate cancer into the abdomen. Furthermore, dissection along the splenic vessels can be extended up to the splenic hilum allowing splenic preservation if the whole pancreas must be resected [12, 16, 17].
Removal of all small vessels, nerves, and lymphatic nodes and networks within the retroperitoneal adipose tissue, the so-called “Total Mesopancreas Excision,” increases the rate of negative resection margins, thus reducing the local recurrence rate and improving the survival [20, 21, 42]. The MP is the retroperitoneal thin soft tissue, within retropancreatic attachments comprising connective tissue, perivascular nervous plexus, and lymph nodes belonging to posterior pancreaticoduodenal vessels. The term MP seems to replace or rather include the classical term of retroportal lamina (RPL), retroperitoneal/posteromedial margin, or retropancreatic capsule, which has a frontal disposition between the pancreas and the SMA [10, 14, 15, 20, 21]. The MP is of great interest with respect to curative resection in malignancies since it is the primary site for R1 resection [21, 43]. In our series, the positive resection margins-R1 (5 patients) were associated to borderline resectable pancreatic head cancers and extended to uncinate, but the rate (14%) is lower than that reported in the literature for similar cases (18–24%) [11, 44]. MP dissection remains one of the most challenging steps in PD no matter what type of approach is used (standard, posterior, or artery first below the pancreas). At present, there is no evidence based on large series concerning the benefits of the “MP first” or “artery first” approaches over the standard PD . A drawback of our study is the heterogeneity of the indications and pathology conditions for PD (malignant/benign diseases, IPMN). Therefore, a comparative study with a matching cohort of patients undergoing standard PD should be difficult. As a matter of fact, this was not an end-point of our study, but to highlight the advantages of our approach in selected indications of PD. Further prospective randomized studies are necessary to assess the real clinical impact of the MP excision in achieving negative resection margins, decreasing local recurrence, and improving the long-term survival of patients resected for pancreatic cancer.
It is worth noting that a limitation of the retropancreatic approach PD was reported in obese patients and those with extensive peripancreatic inflammation . Nevertheless, the surgeon should face the same concern in standard PD too. We encountered this problem in our patients with chronic pancreatitis and those with previous chemotherapy. These conditions render the procedure more difficult rather during vascular isolation and dissection. However, since our approach early exposes the retropancreatic vasculature and dissects the portomesenteric vein below the pancreas and uncinate, it comes to be useful even in peripancreatic inflammation, as it facilitates retropancreatic tunneling above PV and whole pancreas mobilization before transection.
In conclusion, early hind right dissection combined with early exposure of the SMV below the pancreas is a useful technique to expose the retro- and infrapancreatic mesenteric vasculature early during PD. Because of its advantages, we use it routinely in patients with HA anatomic variants, suspected SMA involvement, limited invasion of the mesentericoportal axis, MD-IPMN, and bleeding pancreatic head pseudoaneurysm. MP first dissection facilitates the radicality and safety of PD and enables early vascular control. Further prospective studies are required to assess its advantages over standard PD, since there is no consensus worldwide.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
- C. J. Yeo, J. L. Cameron, T. A. Sohn et al., “Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes,” Annals of Surgery, vol. 226, no. 3, pp. 248–260, 1997.
- J. H. Balcom, D. W. Rattner, A. L. Warshaw, Y. Chang, and C. Fernandez-Del Castillo, “Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization,” Archives of Surgery, vol. 136, no. 4, pp. 391–398, 2001.
- C. J. Yeo, J. L. Cameron, M. M. Maher et al., “A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy,” Annals of Surgery, vol. 222, no. 4, pp. 580–592, 1995.
- R. B. Jagad, M. Koshariya, J. Kawamoto et al., “Pancreatic neuroendocrine tumors: our approach,” Hepato-Gastroenterology, vol. 55, no. 81, pp. 275–281, 2008.
- C. Lupascu, R. Moldovanu, D. Andronic et al., “Posterior approach pancreaticoduodenectomy: best option for hepatic artery anatomical variants,” Hepato-Gastroenterology, vol. 58, no. 112, pp. 2112–2114, 2011.
- C. Lupascu, D. Andronic, C. Ursulescu, C. Vasiluta, and N. Vlad, “Technical tailoring of pancreaticoduodenectomy in patients with hepatic artery anatomic variants,” Hepatobiliary and Pancreatic Diseases International, vol. 10, no. 6, pp. 638–643, 2011.
- M. I. Van Berge Henegouwen, T. M. Moojen, T. M. Van Gulik, E. A. J. Rauws, H. Obertop, and D. J. Gouma, “Postoperative weight gain after standard Whipple's procedure versus pylorus-preserving pancreatoduodenectomy: the influence of tumour status,” British Journal of Surgery, vol. 85, no. 7, pp. 922–926, 1998.
- L. C. Carey, “Pancreaticoduodenectomy,” The American Journal of Surgery, vol. 164, no. 2, pp. 153–162, 1992.
- M. B. Farnell, M. B. Farnell, D. M. Nagorney, D. M. Nagorney, M. G. Sarr, and M. G. Sarr, “The mayo clinic approach to the surgical treatment of adenocarcinoma of the pancreas,” Surgical Clinics of North America, vol. 81, no. 3, pp. 611–623, 2001.
- M. Richelme, Y. Birtwisle, C. Michetti, and A. Bourgeon, “Les attaches postérieures du pancréas. Incidences chirurgicales de la lame rétropancréatique droite,” Chirurgie, vol. 110, pp. 150–157, 1984.
- H. Kitagawa, H. Tajima, H. Nakagawara et al., “En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma,” Molecular Clinical Oncology, vol. 2, no. 3, pp. 369–374, 2014.
- M. Tanaka, C. Fernández-del Castillo, V. Adsay et al., “International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas,” Pancreatology, vol. 12, no. 3, pp. 183–197, 2012.
- P. Sanjay, K. Takaori, S. Govil, S. V. Shrikhande, and J. A. Windsor, ““Artery-first” approaches to pancreatoduodenectomy,” British Journal of Surgery, vol. 99, no. 8, pp. 1027–1035, 2012.
- P. Pessaux, N. Regenet, and J. P. Arnaud, “Resection of the retroportal pancreatic lamina during pancreaticoduodenectomy: first dissection of the superior mesenteric artery,” Annales de Chirurgie, vol. 128, no. 9, pp. 633–636, 2003.
- A. Pissas, “Essai d'anatomie clinique et chirurgicale sur la circulation lymphatique du pancréas,” Journal de Chirurgie, vol. 121, pp. 557–571, 1984.
- L. W. Traverso, E. A. Peralta, J. A. Ryan Jr., and R. A. Kozarek, “Intraductal neoplasms of the pancreas,” The American Journal of Surgery, vol. 175, no. 5, pp. 426–432, 1998.
- F. Paye, A. Sauvanet, B. Terris et al., “Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination,” Surgery, vol. 127, no. 5, pp. 536–544, 2000.
- P. Bachellier, H. Nakano, E. Oussoultzoglou et al., “Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?” The American Journal of Surgery, vol. 182, no. 2, pp. 120–129, 2001.
- R. J. Bold, C. Charnsangavej, K. R. Cleary et al., “Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, introperative , and pathologic analysis,” Journal of Gastrointestinal Surgery, vol. 3, no. 3, pp. 233–243, 1999.
- I. Popescu and T. Dumitrascu, “Total meso-pancreas excision: key point of resection in pancreatic head adenocarcinoma,” Hepato-Gastroenterology, vol. 58, no. 105, pp. 202–207, 2011.
- I. Gockel, M. Domeyer, T. Wolloscheck, M. A. Konerding, and T. Junginger, “Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space,” World Journal of Surgical Oncology, vol. 5, article 44, 2007.
- V. Braşoveanu, T. Dumitraşcu, N. Bacalbaşa, and R. Zamfir, “Splenic artery used for replaced common hepatic artery reconstruction during pancreatoduodenectomy—a case report,” Chirurgia, vol. 104, no. 4, pp. 499–504, 2009.
- S. D. Leach, B. S. Davidson, F. C. Ames, and D. B. Evans, “Alternative method for exposure of the retropancreatic mesenteric vasculature during total pancreatectomy,” Journal of Surgical Oncology, vol. 61, pp. 163–165, 1996.
- M. C. C. Machado, S. Penteado, J. E. M. Cunha et al., “Pancreatic head tumors with portal vein involvement: an alternative surgical approach,” Hepato-Gastroenterology, vol. 48, no. 41, pp. 1486–1487, 2001.
- I. Popescu, L. David, A. Dumitra, and B. Dorobantu, “The posterior approach in pancreaticoduodenectomy: preliminary results,” Hepato-Gastroenterology, vol. 54, no. 75, pp. 921–926, 2007.
- J. B. Rose, F. Rocha, A. Alseidi, and S. Helton, “Posterior “superior mesenteric artery first” approach for resection of locally advanced pancreatic cancer,” Annals of Surgical Oncology, vol. 21, no. 6, pp. 1927–1928, 2013.
- S. Pedrazzoli, V. DiCarlo, R. Dionigi et al., “Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study,” Annals of Surgery, vol. 228, no. 4, pp. 508–517, 1998.
- C. J. Yeo, J. L. Cameron, K. D. Lillemoe et al., “Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality,” Annals of Surgery, vol. 236, no. 3, pp. 355–368, 2002.
- C. M. Volpe, S. Peterson, E. L. Hoover, and R. J. Doerr, “Justification for visceral angiography prior to pancreaticoduodenectomy,” American Surgeon, vol. 64, no. 8, pp. 758–761, 1998.
- M. S. Woods and L. W. Traverso, “Sparing a replaced common hepatic artery during pancreaticoduodenectomy,” The American Surgeon, vol. 59, no. 11, pp. 719–721, 1993.
- F. Yang, J. Long, D. Fu et al., “Aberrant hepatic artery in patients undergoing pancreaticoduodenectomy,” Pancreatology, vol. 8, no. 1, pp. 50–54, 2008.
- L. W. Traverso and P. C. Freeny, “Pancreaticoduodenectomy, the importance of preserving hepatic blood flow to prevent biliary fistula,” American Surgeon, vol. 55, no. 7, pp. 421–426, 1989.
- S. H. Yang, Y. H. Yin, J. Jang et al., “Assessment of hepatic arterial anatomy in keeping with preservation of the vasculature while performing pancreatoduodenectomy: an opinion,” World Journal of Surgery, vol. 31, no. 12, pp. 2384–2391, 2007.
- A. Koops, B. Wojciechowski, D. C. Broering, G. Adam, and G. Krupski-Berdien, “Anatomic variations of the hepatic arteries in 604 selective celiac and superior mesenteric angiographies,” Surgical and Radiologic Anatomy, vol. 26, no. 3, pp. 239–244, 2004.
- S. Yamamoto, K. Kubota, K. Rokkaku, T. Nemoto, and A. Sakuma, “Disposal of replaced common hepatic artery coursing within the pancreas during pancreatoduodenectomy: report of a case,” Surgery Today, vol. 35, no. 11, pp. 984–987, 2005.
- J. Lee, Y. Lee, C. Kim, K. Moon, and M. Kim, “Clinical implications of an aberrant right hepatic artery in patients undergoing pancreaticoduodenectomy,” World Journal of Surgery, vol. 33, no. 8, pp. 1727–1732, 2009.
- N. A. Michels, Blood Supply and Anatomy of the Upper Abdominal Organs with a Descriptive Atlas, Philadelphia, Pa, USA, Lippincott, 1955.
- L. G. Koniaris, L. O. Schoeniger, S. Kovach, and V. J. Sitzmann, “The quick, no-twist, no-kink portal confluence reconstruction,” Journal of the American College of Surgeons, vol. 196, no. 3, pp. 490–494, 2003.
- L. E. Harrison, D. S. Klimstra, and M. F. Brennan, “Isolated portal vein involvement in pancreatic adenocarcinoma: a contraindication for resection?” Annals of Surgery, vol. 224, no. 3, pp. 342–349, 1996.
- S. C. Moldovan, A. M. Moldovan, T. Dumitraæcu, S. Andrei, and I. Popescu, “The advantages of retropancreatic vascular dissection for pancreatic head cancer with portal/superior mesenteric vein invasion: posterior approach pancreatico-duodenectomy technique and the mesopancreas theory,” Chirurgia, vol. 107, no. 5, pp. 571–578, 2012.
- S. Fujisaki, R. Tomita, and M. Fukuzawa, “Utility of mobilization of the right colon and the root of the mesentery for avoiding vein grafting during reconstruction of the portal vein,” Journal of the American College of Surgeons, vol. 193, no. 5, pp. 576–578, 2001.
- M. Adham and J. Singhirunnusorn, “Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors,” European Journal of Surgical Oncology, vol. 38, no. 4, pp. 340–345, 2012.
- N. Peparini and P. Chirletti, “Mesopancreas: a boundless structure, namely R1 risk in pancreaticoduodenectomy for pancreatic head carcinoma,” European Journal of Surgical Oncology, vol. 39, no. 12, pp. 1303–1308, 2013.
- R. P. Merkow, K. Y. Bilimoria, D. J. Bentrem et al., “National assessment of margin status as a quality indicator after pancreatic cancer surgery,” Annals of Surgical Oncology, vol. 21, no. 4, pp. 1067–1074, 2014.
- T. Dumitrascu, L. David, and I. Popescu, “Posterior versus standard approach in pancreatoduodenectomy: a case-match study,” Langenbeck's Archives of Surgery, vol. 395, no. 6, pp. 677–684, 2010.
Copyright © 2014 Stefan Georgescu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.